about
Flash mob research: a single-day, multicenter, resident-directed study of respiratory rate.CDK7-dependent transcriptional addiction in triple-negative breast cancer.TGF-beta promotes cell death and suppresses lactation during the second stage of mammary involutionThe effect of reducing maximum shift lengths to 16 hours on internal medicine interns' educational opportunitiesResponse and resistance to BET bromodomain inhibitors in triple-negative breast cancerCombination inhibition of PI3K and mTORC1 yields durable remissions in mice bearing orthotopic patient-derived xenografts of HER2-positive breast cancer brain metastases.The Role of Proliferation in Determining Response to Neoadjuvant Chemotherapy in Breast Cancer: A Gene Expression-Based Meta-Analysis.Integrin-β4 identifies cancer stem cell-enriched populations of partially mesenchymal carcinoma cells.Intracardiac thrombus: diagnosis, complications and management.Precision medicine in breast cancer: genes, genomes, and the future of genomically driven treatments.Presentation of a medullary endocrine neoplasia 2A kindred with Cushing's syndrome.Tailoring adjuvant chemotherapy regimens for patients with triple negative breast cancer.Long-term impact of prior rituximab therapy and early lymphocyte recovery on auto-SCT outcome for diffuse large B-cell lymphoma.Phase I trial of pemetrexed plus oxaliplatin administered every other week in patients with metastatic cancer.Anti-N-methyl-D-aspartate receptor encephalitis in a young woman with a mature mediastinal teratoma.Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors.CDK12 Inhibition Reverses De Novo and Acquired PARP Inhibitor Resistance in BRCA Wild-Type and Mutated Models of Triple-Negative Breast Cancer.Morbidity and mortality revisited: applying a new quality improvement paradigm in oncology.Association of Cell-Free DNA Tumor Fraction and Somatic Copy Number Alterations With Survival in Metastatic Triple-Negative Breast Cancer.Identification of cancer genes that are independent of dominant proliferation and lineage programs.Restoring Balance: Paraneoplastic Cerebellar Degeneration.Phase II study of ruxolitinib, a selective JAK1/2 inhibitor, in patients with metastatic triple-negative breast cancer.Homologous recombination deficiency and host anti-tumor immunity in triple-negative breast cancerChemotherapy-Exacerbated Breast Cancer Metastasis: A Paradox Explainable by Dysregulated Adaptive-ResponseTumor fraction in cell-free DNA as a biomarker in prostate cancerBRAF and AXL oncogenes drive RIPK3 expression loss in cancerER+ Breast Cancers Resistant to Prolonged Neoadjuvant Letrozole Exhibit an E2F4 Transcriptional Program Sensitive to CDK4/6 InhibitorsGenomic and Transcriptomic Landscape of Triple-Negative Breast Cancers: Subtypes and Treatment StrategiesCaveat arthroplasty.Mutational status of overexpressed p16 in head and neck cancer: evidence for germline mutation of p16/p14ARFImplementing Liquid Biopsies in Clinical Trials: State of Affairs, Opportunities, and ChallengesSupporting the Future of the Oncology Workforce: ASCO Medical Student and Trainee InitiativesIdentification of Alternatively-Activated Pathways between Primary Breast Cancer and Liver Metastatic Cancer Using Microarray DataSensitive detection of minimal residual disease in patients treated for early-stage breast cancerAggressive Subsets of Metastatic Triple Negative Breast CancerThe Omics Revolution Continues: The Maturation of High-Throughput Biological Data SourcesFractional CO2 laser therapy for genitourinary syndrome of menopause for breast cancer survivorsThe Immune Microenvironment in Hormone Receptor-Positive Breast Cancer Before and After Preoperative ChemotherapyAbrupt involution induces inflammation, estrogenic signaling, and hyperplasia linking lack of breastfeeding with increased risk of breast cancerAssessment of outcomes and novel immune biomarkers in metaplastic breast cancer: a single institution retrospective study
P50
Q30412729-B83AA770-695A-47D0-87AB-E71A765C2149Q34495729-47ED6418-D402-488D-A885-CA954AEEE416Q34571586-730FDF0D-4FA5-46E2-B0F9-B4D834126F6AQ36802665-8DD103AE-89EB-4C19-AA2E-5F12F76DBC31Q36862936-B75F3C08-7BB8-4959-ABA7-D973DBF95928Q37079718-4815D915-4854-482E-B47A-AA9F3E197F80Q37510518-AA92916E-6DB4-4654-ACCB-3373D1B114ABQ37730158-BAFAB6BF-D174-48EF-89C5-BA9D7ECA60F4Q38074815-9EF35D6B-F1F1-4762-A9E6-8826CCA0E777Q38364614-4FEED2FE-5629-412D-8C42-2ECF33FA5FCEQ38499805-25562A29-8E00-420A-9E64-F7E25A8D714BQ38563043-B916AB34-0E21-4F76-93A1-65909D4C4F02Q39777744-F1F0AF5E-F6D0-40A1-BC47-DAAC1B535B79Q40419686-23F28554-4581-40C6-9B3C-DDB0481F7716Q42848016-7AA4A09F-B1C5-4B69-9F3E-6667A8808EC6Q43045850-C5C39C39-9589-4033-9333-328757025C1DQ43898530-611B2E51-DA90-43D6-8F78-BBB88E27DFCDQ47155673-F7DFC535-2ABE-43F9-8925-916EC3096FA7Q47214510-FDDF3B43-9B99-45C3-B1C6-DBF7E8BC8997Q47327357-9571D3DE-33CC-46AF-89E0-F4E719AE76E0Q48438937-45122220-1BEE-4305-A52E-2CCDC67C82D0Q55387796-11213C6B-5B09-4607-857D-1237C43AA390Q57112945-97E39CD5-BF34-410E-97E8-A4D26B850A74Q58114545-A944D953-95B4-4B5D-995D-3483E288521CQ58617288-E6E63ADD-97F4-42ED-9395-12798842B098Q58696646-508AB854-1A35-4328-9BA0-97316120BD1DQ62785312-A5EC5CCF-FA3C-428A-8E21-A73E108D304CQ64113838-A0B53AC4-09DF-490F-A764-BF576CEA6CDBQ64975681-C2695C71-52AF-405C-9B49-55A7E9F0879FQ74463093-5DC7B059-1154-48DA-B351-9D98CFE47EC0Q88225393-02E4D4E3-AEEA-45FF-AB2A-2B31205DA3B4Q88421117-FF1A9E9E-AA0F-45D6-984C-3884A77E4F6EQ90312211-82BF653F-F154-4CBC-933A-166CA14C33BFQ90316165-891F7672-5CCA-4634-A082-06296AC9B6A3Q90828983-E93391E2-1F04-4BA1-B3F1-5C688DAEB422Q91203601-C0B5884A-88B4-40A1-9B1A-CC24C5644E34Q91770122-08A1ADA8-B576-45BC-8925-B166A5742BF3Q91802795-F57DCE39-C1D8-4CBA-9E38-9DEB73A4A353Q91964812-F2534047-2A29-459A-A1E5-3CA6A95342C7Q92640014-A84EEA90-EA6C-4B81-8206-DF3B9F14FEF2
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Daniel G Stover
@ast
Daniel G Stover
@en
Daniel G Stover
@es
Daniel G Stover
@fr
Daniel G Stover
@nl
Daniel G Stover
@sl
type
label
Daniel G Stover
@ast
Daniel G Stover
@en
Daniel G Stover
@es
Daniel G Stover
@fr
Daniel G Stover
@nl
Daniel G Stover
@sl
prefLabel
Daniel G Stover
@ast
Daniel G Stover
@en
Daniel G Stover
@es
Daniel G Stover
@fr
Daniel G Stover
@nl
Daniel G Stover
@sl
P106
P21
P31
P496
0000-0001-9003-8165